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Abstract Although oxidative stress is commonly associated
with apoptosis, its speci¢c role in the execution of the apoptotic
program has yet to be described. We hypothesized that catalytic
redox interactions between negatively charged phosphatidylser-
ine (PS) and positively charged cytochrome c released into the
cytosol, along with the production of reactive oxygen species
(ROS), results in pronounced oxidation and externalization of
PS, and subsequent recognition of apoptotic cells by macro-
phages. By using staurosporine, a protein kinase inhibitor that
does not act as a prooxidant, we were able to induce apoptosis
in HL-60 cells without triggering the confounding e¡ects of non-
speci¢c oxidation reactions. Through this approach, we demon-
strated for the ¢rst time that PS underwent a statistically sig-
ni¢cant and pronounced oxidation at an early stage (2 h) of
non-oxidant-induced apoptosis while the most abundant phos-
pholipid, phosphatidylcholine, did not. Glutathione (GSH), the
most abundant cytosolic thiol, also remained unoxidized at this
time point. Furthermore, PS oxidation and the appearance of
cytochrome c in the cytosol were concurrent; PS externalization
was followed by phagocytosis of apoptotic cells. These ¢ndings
are compatible with our proposed roles for oxidative PS-depen-
dent signaling during apoptosis and phagocytosis. 1 2002
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1. Introduction
Many di¡erent prooxidants such as redox-cycling chemi-
cals, photosensitizers, and UV- and X-irradiation cause apo-
ptosis because of their propensity to induce oxidative stress.
These exogenous agents trigger apoptosis through oxidative
modi¢cation of critical intracellular targets, particularly DNA
and mitochondria (reviewed in [1,2]). Once initiated, apoptosis
inevitably involves production of reactive oxygen species
(ROS) by mitochondria as an intrinsic part of executing of
the apoptotic program [3]. This ‘endogenous’ oxidative stress
is mainly caused by the departure of cytochrome c from mi-
tochondria, disruption of electron transport, impairment of
proton £ow and decrease of the mitochondrial transmem-
brane potential, and excessive generation of superoxide (O32 )
and hydrogen peroxide (H2O2) [4,5]. The role of this ‘endog-
enous’ oxidative stress in subsequent stages of the apoptotic
program and in signaling is not well understood. In fact,
whether it is an unavoidable but useless side e¡ect of apopto-
sis or a critical feature of the apoptotic cascades through
modi¢cation of redox-sensitive mechanisms (e.g. mitochon-
drial permeability transition pore (reviewed in [6]) and cas-
pases [7]) is not quite clear.
Phospholipids and their enzymatic and non-enzymatic oxi-
dation products, such as eicosanoids, lipoxins, and isopros-
tanes, are known to function as physiologically important
signaling molecules (reviewed in [8^10]). It is possible that
oxidation-sensitive polyunsaturated phospholipids may partic-
ipate in signaling during apoptosis. Unfortunately, informa-
tion on peroxidation of phospholipids during apoptosis is
scarce primarily because quantitative assays for oxidation of
di¡erent classes of phospholipids are not readily available.
One major reason for this is a very e¡ective system of remod-
eling and repair of oxidatively modi¢ed phospholipids [11]
that interferes with their accurate measurement.
We have recently developed and optimized a technique for
quantitative assessment of oxidative stress in di¡erent classes
of phospholipids in live cells: through metabolic labeling of
phospholipids with an oxidation-sensitive £uorescent fatty
acid, cis-parinaric acid (PnA) [11].
We previously reported that phosphatidylserine (PS) under-
went more pronounced oxidation than other phospholipids
such as phosphatidylcholine (PC), phosphatidylethanolamine
(PE), and sphingomyelin during oxidant-induced apoptosis
[12]. We hypothesized that PS oxidation is associated with
its externalization on the surface of the plasma membrane
during apoptosis [13]. PS externalization is an early, promi-
nent feature of apoptosis [14] and acts as an important rec-
ognition signal for phagocytosis of apoptotic cells [15] ; on
that basis we further speculated that PS oxidation may be
involved in a signaling pathway responsible for safe clearance
of apoptotic cells by macrophages [12,13]. The hypothesis
implies that PS is oxidized during execution of the apoptotic
program. While our earlier results provided some indirect evi-
dence in favor of this hypothesis, we failed to detect prefer-
ential oxidation of PS due to massive oxidation of essentially
all types of phospholipids during oxidant-induced apoptosis.
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Obviously, a model of non-oxidant-induced apoptosis should
be evaluated to avoid the confounding e¡ects of non-speci¢c
oxidation.
Therefore, we used a model of staurosporine (STS)-induced
apoptosis to determine whether PS oxidation may be recog-
nized as a selective oxidative signal associated with the execu-
tion of apoptotic program. It has been shown that STS, a
potent protein kinase C inhibitor with a broad spectrum of
activity [16], induces apoptotic cell death in a number of dif-
ferent cell lines [4,17^20]. Importantly, STS also induces oxi-
dative stress in various cells even though it does not act as a
chemical oxidant [4,21^23].
In the present study, we assessed PS oxidation and external-
ization during STS-induced apoptosis in HL-60 cells. We
demonstrated that PS undergoes pronounced oxidation as
compared to PC, the most abundant membrane phospholipid,
during STS-induced apoptosis. We further showed that this
PS oxidation occurred concurrently with the onset of (1) cy-
tochrome c release, (2) PS externalization and (3) phagocyto-
sis of the apoptotic cells by macrophages. These results
strongly suggest that generation of ROS and subsequent PS
oxidation are features of early apoptosis and likely participate
in PS-dependent signaling pathways involved in clearance of
apoptotic cells.
2. Materials and methods
2.1. Materials
STS, fetal bovine serum (FBS), dimethyl sulfoxide (DMSO), re-
duced glutathione (GSH) and Hoechst 33342 were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). HPLC solvents (metha-
nol, chloroform, and hexane) were obtained from Aldrich Chemical
Co. (Milwaukee, WI, USA). 7-Amino-4-methyl-coumarin (AMC) and
acetyl-Asp-Glu-Val-Asp-MCA (Ac-DEVD-AMC) were purchased
from Peptides International (Louisville, KY, USA). ThioGlo-11 ma-
leimide reagent was obtained from Covalent Associates Inc. (Woburn,
MA, USA). Cell Tracker Orange1 and PnA (Z-9, E-11, E-13, Z-15-
octadecatetraenoic acid) were purchased from Molecular Probes (Eu-
gene, OR, USA). Dulbecco’s modi¢ed Eagle’s medium (DMEM) and
RPMI 1640 medium were obtained from Gibco BRL Products
(Grand Island, NY, USA). The purity of PnA was determined by
UV spectrophotometry at 304 nm in ethanol (O=80 mM31 cm31).
All other chemicals were of analytical grade.
2.2. Cell culture
Human promyelocytic leukemia HL-60 cells were grown in RPMI
1640 medium supplemented with 12.5% heat-inactivated FBS at 37‡C
in a humidi¢ed incubator and 5% CO2+95% air. Cells were seeded at
a concentration of 2U105 cells/ml and logarithmic growth was main-
tained by passaging every 2^3 days. All current experiments were
performed using RPMI 1640 medium containing 12.5% FBS and
1U106 cells/ml, unless speci¢ed otherwise.
Murine macrophages (J774A.1, cell line obtained from ATCC) were
grown in DMEM supplemented with 10% heat-inactivated FBS, 100
U/ml penicillin, 100 Wg/ml streptomycin, and 50 Wg/ml gentamicin
sulfate and were incubated in a humidi¢ed atmosphere (5%
CO2+95% air) at 37‡C.
2.3. Determination of apoptotic cells by nuclear morphology
HL-60 cells (1U106 cells/ml) were incubated with 1 WM STS at
37‡C for 1^6 h, washed with phosphate-bu¡ered saline (PBS), and
then ¢xed with 2% glutaraldehyde for 2 h. Samples (1U106 cells/
100 Wl) were then centrifuged, washed, resuspended with PBS, and
stained with Hoechst 33342 (5 Wg/ml). They were subsequently
mounted on glass slides and observed under a Nikon ECLIPSE TE
200 £uorescence microscope (Tokyo, Japan) equipped with digital
Hamamatsu CCD camera (C4742-95-12NBR). Results were expressed
as the percentage of the cells showing characteristic nuclear morpho-
logical features of apoptosis (nuclear condensation and fragmenta-
tion) relative to the total number of counted cells. (For each time
point, v 200 total cells were evaluated.)
2.4. Determination of caspase-3 activity
The activity of caspase-3 was determined as described previously
[24]. Brie£y, after STS treatment, cells were collected, washed in PBS,
and lysed for 20 min on ice in lysis bu¡er containing 10 mM HEPES^
KOH (pH 7.4); 2 mM EDTA; 0.1% CHAPS; 1 mM phenylmethyl-
sulfonyl £uoride (PMSF); and 5 mM dithiothreitol (DTT). The sus-
pensions were centrifuged at 4‡C and the supernatants were collected
as lysates. For measurement of caspase activity, 10 Wg of lysate was
diluted to 20 Wl with lysis bu¡er, mixed with 20 Wl 2UICE bu¡er
(40 mM HEPES^KOH (pH 7.4), 20% (v/v) glycerol, 1 mM PMSF
and 4 mM DTT) containing 40 WM Ac-DEVD-AMC (a £uorogenic
peptide substrate), and incubated for 60 min at 37‡C. After 60 min,
460 Wl of distilled water was added, and the £uorescence was mea-
sured in a CytoFluor 2350 (Millipore, Bedford, MA, USA) £uores-
cence microplate reader set at an excitation wavelength of 360V 40 nm
and an emission of 460V 40 nm. One unit of caspase activity was
de¢ned as the amount of enzyme required to release 1 pmol AMC
per min.
The protein concentration of cell lysates was measured by the meth-
od of Bradford [25].
2.5. Flow cytometry of PS externalization
Annexin V binding to cells was determined using a commercially
available staining kit (Biovision, Mountain View, CA, USA) and £ow
cytometry as previously described [26]. Brie£y, after treatment with
STS, HL-60 cells were recovered and washed once with PBS. Cells
were labeled with FITC-conjugated annexin V and propidium iodide
(PI) for 5 min, and immediately analyzed with a FACScan £ow cy-
tometer (Becton Dickinson, San Jose, CA, USA) with simultaneous
monitoring of green £uorescence (530 nm, 30 nm band-pass ¢lter) for
annexin V^FITC and red £uorescence (long-pass emission ¢lter that
transmits light s 650 nm) associated with PI.
2.6. Determination of phospholipid peroxidation in HL-60 cells
PnA is a natural 18-carbon fatty acid with four conjugated double
bonds. PnA is highly susceptible to peroxidation and also £uorescent.
The £uorescence is irreversibly lost upon peroxidation, providing a
convenient approach for quantifying lipid peroxidation [27,28]. PnA is
used as a reporter molecule for assay of membrane lipid peroxidation
in intact mammalian cells. PnA was metabolically incorporated into
HL-60 cell phospholipids (1U106 cells/ml) by addition of PnA^human
serum albumin complex to give a ¢nal concentration of 2.5 Wg PnA/
106 cells in FBS-free RPMI 1640 medium without phenol red. Cells
were incubated for 2 h at 37‡C in the dark. Thereafter, PnA-labeled
cells were resuspended in RPMI 1640 supplemented with 12.5% FBS
and incubated with 1 WM STS at 37‡C for an indicated period of time.
At the end of each incubation period, phospholipid oxidation was
determined according to previously described methods [11].
2.7. Preparation of mitochondrial and cytosolic fractions and
quanti¢cation of cytochrome c
HL-60 cells were treated with 1 WM STS, harvested, and washed
three times with ice-cold PBS. Cells were resuspended in isotonic bu¡-
er A (10 mM HEPES, 0.3 M mannitol and 0.1% BSA), supplemented
with 0.1 mM digitonin (1.5U106 cells/ml), left on ice for 5 min, and
immediately centrifuged at 8500Ug for 5 min at 4‡C. The collected
supernatant was used as the cytosolic fraction. The pellet was resus-
pended in sonication bu¡er (50 mM Tris^HCl, pH 7.4, 150 mM NaCl,
2 mM EDTA, 1 mM PMSF and 0.5% Tween 20), sonicated three
times (20 s each) on ice, and centrifuged at 10 000Ug for 30 min at
4‡C; the resulting supernatant was used as the mitochondrial fraction.
The amount of cytochrome c in mitochondrial and cytosolic fractions
was measured with a commercially available cytochrome c ELISA kit
(Oncogene Research Products, San Diego, CA, USA) according to the
manufacturer’s instructions, after appropriate dilution.
2.8. Determination of intracellular GSH contents
HL-60 cells (1U106 cells/ml) were incubated (at 37‡C in 5% CO2) in
the absence or presence of 1 WM STS in RPMI 1640 medium for 0, 1,
2, 4, and 6 h. After treatments, cells were harvested, and the gluta-
thione content was determined £uorometrically using ThioGlo-11 as
previously described [29]. Brie£y, harvested treated and untreated cells
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were washed and resuspended with PBS and lysed by freezing and
thawing once. Immediately after adding 10 WM ThioGlo-11 to the
lysates, £uorescence was measured in a CytoFluor 2350 (Millipore)
£uorescence microplate reader set at an excitation wavelength of
360V 40 nm and emission, at 530V 25 nm.
The protein concentration of cell lysates was measured by the meth-
od of Bradford [25].
2.9. Phagocytosis of HL-60 cells by macrophages
Macrophage J774A.1 cells were used for phagocytosis assays. Be-
fore adding target (STS-treated or untreated HL-60) cells, macro-
phages were seeded into an 8-well chamber slide (5U104 cells/well)
and were cultured overnight. HL-60 cells were labeled with Cell
Tracker Orange1 for 15 min at 37‡C and then exposed to 1 WM
STS for 3 h. The cells were subsequently washed and resuspended
in serum-containing RPMI medium. Fluorescently labeled cells
(5U105 cells/well) were added to macrophage cultures, and each mix-
ture was incubated for 1 h at 37‡C; unbound cells were then washed
three times with RPMI medium and then three times with PBS. Well
contents were ¢xed and stained with a ¢xing solution (2% parafor-
maldehyde, in PBS containing 1 Wg/ml Hoechst 33342 (a blue £uores-
cent stain for nuclei)) for 30 min at room temperature. The cells were
examined under a Nikon ECLIPSE TE 200 £uorescence microscope
(Tokyo, Japan) equipped with digital Hamamatsu CCD camera
(C4742-95-12NBR) and analyzed using the MetaImaging Series1
software v.4.6 (Universal Imaging Corp., Downingtown, PA, USA).
A minimum of 500 macrophages were analyzed per experimental con-
dition. Results were expressed as the percentage of the phagocytosis-
positive macrophages.
2.10. Statistical evaluations
Data are expressed as meanV standard error of the mean (S.E.M.).
Changes in variables for di¡erent assays were analyzed either by Stu-
dent’s t-test (single comparisons) or by one-way ANOVA for multiple
comparisons. Di¡erences were considered to be signi¢cant at P6 0.05.
3. Results
3.1. Time-course of STS-induced apoptosis in HL-60 cells
To characterize apoptosis in HL-60 cells, we studied the
time-course (from 1 to 6 h) of (i) the appearance of typical
nuclear morphology in the cells, (ii) caspase-3 activation,
(iii) PS externalization, and (iv) release of cytochrome c
from mitochondria after the cells were exposed to STS.
Fig. 1. Time-course of biomarkers of apoptosis in HL-60 cells exposed to STS. Cells (1U106 cells/ml) were incubated at 37‡C under 5% CO2/
95% air atmosphere in the absence or presence of 1 WM STS for the indicated time periods. A: Apoptotic cells were determined by nuclear
morphological examination with Hoechst 33342 staining. B: Caspase-3 activity was measured using £uorescent substrates. Data points represent
the meanVS.E.M. of three to ¢ve separate experiments. Note: some error bars are too small to be seen. (*P6 0.01 vs. control at the same
time period). C: PS externalization was determined by annexin V binding assayed by £ow. D: Cytochrome c content in the cytosolic (open
circles) and mitochondrial (solid circles) fractions assayed by ELISA. Data are meanVS.E.M. of three separate experiments. *P6 0.01 vs. 0-h
control for cytosol, #P6 0.01 vs. 0-h control for mitochondria.
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3.1.1. Accumulation of apoptotic cells. Apoptotic cells be-
came evident 2 h after STS treatment, as assessed by exami-
nation of nuclear morphology; the number of apoptotic cells
increased with time up to 6 h (Fig. 1A) in a manner similar to
caspase-3 activation (Fig. 1B). In control cell cultures, no
accumulation of apoptotic cells was observed.
3.1.2. Caspase-3 activation. After treatment of cells with
STS, a slight but signi¢cant increase in caspase-3 activity was
observed at 2 h; the activity increased prominently and in a
time-dependent manner at later time points (Fig. 1B). Cas-
pase-3 activation was not detected in control cells.
3.1.3. PS externalization. PS externalization from the in-
ner lea£et of the plasma membrane to its outer lea£et is
known to be one of early markers of apoptosis [14]. A sig-
ni¢cant accumulation of apoptotic HL-60 cells with external-
ized PS (de¢ned as annexin V-positive and PI-negative cells)
commenced 2 h after treatment with STS and increased in a
time-dependent manner (Fig. 1C). Notably, the amounts of
annexin V-positive/PI-positive (late apoptotic+necrotic) cells
during STS-induced apoptosis were relatively low and did
not exceed 5.5% of the total number of cells (data not shown).
3.1.4. Cytochrome c e¥ux from mitochondria into the
cytosol. At 2, 3 and 4 h after STS treatment, the contents
of cytochrome c in the cytosol increased 2-, 4-, and 8-fold,
respectively, when compared to that of the controls (time
point 0). Conversely, mitochondrial cytochrome c levels de-
creased after exposure of cells to STS although statistical sig-
ni¢cance was reached only after 3 h (Fig. 1D).
3.2. Time-course of STS-induced oxidative stress in HL-60
cells
Two end-points were assessed to characterize STS-induced
oxidative stress in HL-60 cells : (i) peroxidation of membrane
phospholipids and (ii) loss of intracellular GSH.
3.2.1. Phospholipid peroxidation. Recall that metabolic la-
beling of phospholipids with oxidation-sensitive £uorescent
PnA and HPLC with £uorescence detection was used to assay
phospholipid peroxidation [11]. We found that the most abun-
dant membrane phospholipid in HL-60 cells, PC, did not
undergo statistically signi¢cant peroxidation after 0.5, 1.0,
or 2.0 h of STS treatment (Fig. 2A). In contrast, PS showed
a statistically signi¢cant peroxidation (detected as a loss of
£uorescent PnA^PS) relative to that of the control cells after
2 h exposure to STS (Fig. 2A). No signi¢cant PS oxidation
was detected at earlier time points (0.5 and 1.0 h). Unfortu-
nately, intrinsic £uorescence of STS precluded analysis of per-
oxidation levels of PE and phosphatidylinositol because £uo-
rescent STS co-eluted with this phospholipid, interfering with
accurate detection of its respective peak.
3.2.2. GSH depletion. Measurements of GSH contents in
STS-treated HL-60 cells revealed an approximately 25% de-
crease in GSH concentration occurring only 4 h after STS
treatment. At 6 h after STS exposure, the cells lost W50%
of their GSH (Fig. 2B). No signi¢cant changes in GSH con-
tent were detectable during the initial 2 h of STS exposure.
3.3. Phagocytosis of STS-treated HL-60 cells by J774A.1
macrophages
Externalization of PS on the surface of plasma membrane
acts as a distinctive signal that allows macrophages to recog-
nize and phagocytize apoptotic cells [15]. Because STS-in-
duced apoptosis was accompanied by PS externalization, we
next determined whether recognition and uptake of HL-60
apoptotic cells by macrophages takes place. The percentage
of phagocytosis-positive J774A.1 macrophages with bound
and/or phagocytized STS-treated (1 WM, 3 h) HL-60 cells
was approximately 13V 1% ^ a signi¢cant increase when com-
pared with 4V 1% phagocytosis-positive macrophages ob-
served after co-incubation with untreated HL-60 cells.
4. Discussion
Oxidative stress is both an inducer of apoptosis and an
inherent part of the apoptosis execution program (reviewed
in [1]). H2O2 [7,30,31], peroxynitrite [32,33], and nitric oxide
generators [34,35] are known to induce apoptosis in a variety
of cell types. Furthermore, inhibition of apoptosis by di¡erent
antioxidants such as N-acetyl cysteine [36^38], pyrrolidine di-
thiocarbamate [39], ascorbate [40], and K-tocopherol [40], and
antioxidant enzymes such as catalase [36] suggest that gener-
ation of ROS plays a role in apoptosis in diverse cell lines
[38,41]. However, no speci¢c function for ROS or oxidation
products in apoptotic signaling pathways has been identi¢ed.
We have previously demonstrated that involvement of PS in
peroxidation during oxidant-induced apoptosis in di¡erent
cell lines was disproportionally greater than that of other
more abundant phospholipids such as PC and PE [17]. Given
that transmembrane migration and subsequent externalization
of PS is an important signaling pathway for recognition of
apoptotic cells by macrophages, we hypothesized that PS ox-
idation in plasma membrane may play some, as yet unrecog-
Fig. 2. Time-course of biomarkers of oxidative stress in HL-60 cells
treated with STS. A: Phospholipid peroxidation assayed by £uores-
cence HPLC of PnA-labeled phospholipids. PnA phospholipids (PS,
¢lled columns and PC, clear columns) were detected £uorometrically
at 420 nm under excitation at 324 nm. Data points represent the
meanVS.E.M. of three to ¢ve separate experiments (*P6 0.05 vs.
0-h control). B: Intracellular GSH determined £uorometrically using
ThioGlo-11. Data points represent the meanVS.E.M. of three to
four separate experiments (**P6 0.01 vs. control at the same time
period). Note: some error bars are too small to be seen.
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nized, role in its externalization. We further speculated that
preferential oxidation of negatively charged PS during apo-
ptosis may be related to its binding of positively charged
cytochrome c, which, once released from mitochondria, cata-
lyzes PS oxidation [13]. Experimental testing of this hypoth-
esis in oxidant-induced models of oxidative stress is di⁄cult, if
not impossible, because of the high level of non-speci¢c back-
ground phospholipid peroxidation generated by the oxidants.
This can, however, be determined in models of non-oxidant-
induced apoptosis, during which only speci¢c phospholipid
peroxidation associated with execution of the apoptotic pro-
gram is likely to occur.
In the present work, we chose to use STS to induce apo-
ptosis and associated oxidative stress in HL-60 cells. This is
because STS ^ a non-speci¢c inhibitor of protein kinases [16]
as well as a potent inducer of apoptosis [4,17^20] ^ has been
reported to induce PS externalization [18,42], cytochrome c
release from mitochondria into the cytosol [4,5,17,19,
20,22,42], and ROS generation [4,21^23] during apoptosis.
We found that, indeed, STS was very e¡ective in inducing
apoptosis in HL-60 cells as evidenced by characteristic
changes of nuclear morphology, caspase-3 activation, and,
importantly, PS externalization. Essentially, the time-courses
of all these biomarkers of apoptosis revealed a common pat-
tern: a slight but signi¢cant elevation 2 h after STS exposure
of HL-60 cells, with a dramatic increase at later time points.
In contrast, our assessment of oxidative stress did not show
a uniform response to STS. The most abundant intracellular
oxidation substrate, water-soluble antioxidant GSH, did not
show any signi¢cant oxidation during a 2-h period after treat-
ment of cells with STS and only underwent oxidation after 4 h
of STS exposure; similarly, oxidation of the most abundant
membrane phospholipid, PC, was not detectable for 0.5^2.0 h
of STS exposure. Remarkably, a pronounced peroxidation of
PS was detected after a 2-h exposure to STS, although it was
not detectable at earlier time points (0.5 and 1.0 h). This
preferential oxidation of PS (as compared to more abundant
PC) at early stages of STS-induced apoptosis raises questions
about the potential catalytic mechanisms involved in this pro-
cess.
We have previously hypothesized that release of cyto-
chrome c from mitochondria into the cytosol may facilitate
its electrostatic interactions with PS, resulting in the oxidation
of the latter [13]. This catalytic process requires that ROS (O32
and H2O2) be produced in excess by disrupted mitochondrial
electron transport [4,5]. In the present study, we found that
relatively small but signi¢cantly increased amounts of cyto-
chrome c were detectable in the cytosol of HL-60 cells 2 h
after STS exposure ^ at the time when PS oxidation was
observed. Although cytochrome c may act as a superoxide
scavenger and an antioxidant during electron transport in
mitochondria [43,44] it is likely that it functions as a catalytic
heme-containing prooxidant after being released along with
hydrogen peroxide into the cytosol during STS-induced apo-
ptosis. In fact, our results suggest that relatively small
amounts of cytochrome c in the cytosol are quite su⁄cient
for catalytic PS peroxidation, although similarity of the time-
course for cytochrome c release and PS oxidation may be an
occasional coincidence. Notably, these low concentrations of
cytochrome c in the cytosol are inadequate for GSH or PC
oxidation, implying that speci¢c mechanisms may be involved
in PS oxidation. The actual catalytic mechanisms underlying
PS oxidation during apoptosis and the speci¢c role of cyto-
chrome c in the catalysis remain to be elucidated.
Phospholipid transbilayer asymmetry is primarily main-
tained by two enzymes in plasma membrane [45] : one is an
inward-directed pump ^ an ATP-dependent transporter spe-
ci¢c for aminophospholipids known as aminophospholipid
translocase (APT); the other is a phospholipid scramblase
that facilitates bi-directional migration of all phospholipid
classes. PS externalization during apoptosis is thought to re-
sult from an inhibition of APT activity combined with the
activation of scramblase [45,46]. Although it is still unclear
whether PS oxidation can drive exposure of PS on the outer
lea£et, some potential mechanisms have been proposed. Since
APT is sensitive to oxidative stress [47], ROS and/or oxidized
PS might inhibit APT activity directly. Alternatively, oxidized
PS (in contrast to non-oxidized PS) might avoid APT-depen-
dent transport because of its poor recognition by the enzyme
or because of its rapid £ip-£op movement across the mem-
brane [48]. Further studies are required to reveal the exact
relationships between PS oxidation and externalization.
Nevertheless, our results indicate that both pronounced PS
oxidation and externalization occur in STS-exposed HL-60
cells, rendering them a target for phagocytosis. Indeed, treat-
ment of cells with STS yielded a substantial enhancement of
their binding and uptake by J774A.1 macrophages.
Overall, we established that although STS does not induce
apoptosis by way of non-speci¢c oxidative stress, execution of
the STS-induced apoptotic program is accompanied by an
early pronounced oxidation of PS. The results of our time-
course studies are compatible with the conclusion that PS
oxidation (i) involves PS interaction with cytochrome c re-
leased into the cytosol, where the latter utilizes H2O2 and
other ROS for selective oxidative catalysis; (ii) facilitates PS
externalization on the outer surface of plasma membrane; and
(iii) serves as an additional recognition signal that enhances
phagocytosis of apoptotic cells.
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